Oncotarget at the 2022 AACR Annual Meeting | Oncotarget

Описание к видео Oncotarget at the 2022 AACR Annual Meeting | Oncotarget

BUFFALO, NY-March 28, 2022 – Impact Journals publishes scholarly journals in biomedical sciences with a focus on all areas of cancer and aging research. Impact Journals will be participating as an exhibitor at the American Association for Cancer Research (AACR) 2022 annual meeting from April 8-13, 2022, in New Orleans, Louisiana. This year, the AACR conference is entitled, “Decoding Cancer Complexity | Integrating Science | Transforming Patient Outcomes.”

Oncotarget and Aging (Aging-US) are Impact Journals’ two most prominent journals. Oncotarget is a peer-reviewed, open-access journal dedicated to publishing high-quality, primarily oncology-focused research—in a continuous format within ongoing yearly volumes. Aging is a twice-monthly, traditional, peer-reviewed, open-access journal covering all areas of research on aging, including age-related diseases such as cancer and COVID-19.

Visit booth No. 2012 at the 2022 AACR annual meeting from April 8-13, 2022, to connect with members of the Impact Journals team.

To learn more about Impact Journals, visit https://www.impactjournals.com/.

For media requests, please contact [email protected].

Keywords - cancer, cancer research, open access, peer review, research papers, oncology, oncology research, journal publication, announcement, press release, meeting, conference, aging, longevity, healthspan, lifespan, lifestyle

About Oncotarget

Oncotarget is a peer-reviewed, open access biomedical journal covering research on all aspects of oncology.

To learn more about Oncotarget, please visit https://www.oncotarget.com and connect with us:

SoundCloud -   / oncotarget  
Facebook -   / oncotarget  
Twitter -   / oncotarget  
Instagram -   / oncotargetjrnl  
YouTube -    / oncotargetyoutube  
LinkedIn -   / oncotarget  
Pinterest -   / oncotarget  
Reddit -   / oncotarget  

Oncotarget is published by Impact Journals, LLC: https://www.ImpactJournals.com

Media Contact
[email protected]
18009220957

Комментарии

Информация по комментариям в разработке